Insulin reduces neuronal excitability by turning on GABA(A) channels that generate tonic current.
Insulin signaling to the brain is important not only for metabolic homeostasis but also for higher brain functions such as cognition. GABA (γ-aminobutyric acid) decreases neuronal excitability by activating GABA(A) channels that generate phasic and tonic currents. The level of tonic inhibition in neurons varies. In the hippocampus, interneurons and dentate gyrus granule cells normally have significant tonic currents under basal conditions in contrast to the CA1 pyramidal neurons where it is minimal. Here we show in acute rat hippocampal slices that insulin (1 nM) "turns on" new extrasynaptic GABA(A) channels in CA1 pyramidal neurons resulting in decreased frequency of action potential firing. The channels are activated by more than million times lower GABA concentrations than synaptic channels, generate tonic currents and show outward rectification. The single-channel current amplitude is related to the GABA concentration resulting in a single-channel GABA affinity (EC(50)) in intact CA1 neurons of 17 pM with the maximal current amplitude reached with 1 nM GABA. They are inhibited by GABA(A) antagonists but have novel pharmacology as the benzodiazepine flumazenil and zolpidem are inverse agonists. The results show that tonic rather than synaptic conductances regulate basal neuronal excitability when significant tonic conductance is expressed and demonstrate an unexpected hormonal control of the inhibitory channel subtypes and excitability of hippocampal neurons. The insulin-induced new channels provide a specific target for rescuing cognition in health and disease.
Department of Neuroscience, Uppsala University, Uppsala, Sweden.
Zhe
Z
Jin
Yang
Y
Jin
Suresh
S
Kumar-Mendu
Eva
E
Degerman
Leif
L
Groop
Bryndis
B
Birnir
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D056547:CA1 Region, Hippocampal / Q000166:cytology / Q000502:physiology*; D018118:Chloride Channels / Q000187:drug effects; D055724:Electrophysiological Phenomena; D007328:Insulin / Q000494:pharmacology*; D009474:Neurons / Q000502:physiology*; D051381:Rats; D011963:Receptors, GABA-A / Q000187:drug effects* / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000187:drug effects
D018118:Chloride Channels; D007328:Insulin; D011963:Receptors, GABA-A; D005680:gamma-Aminobutyric Acid
Nat Neurosci. 2003 May;6(5):484-90
12679782
Neurology. 2008 Sep 30;71(14):1065-71
18401020
Mol Pharmacol. 2001 Apr;59(4):814-24
11259626
Brain Res. 1984 Aug 20;309(1):187-91
6386100
Diabetes. 2010 Jan;59(1):4-5
20040482
J Neurophysiol. 2006 May;95(5):2796-807
16452257
J Neurochem. 2006 Jun;97(5):1349-56
16573642
J Neurosci. 2005 Oct 26;25(43):10016-24
16251450
Prog Brain Res. 2007;160:59-87
17499109
J Neurophysiol. 2003 Oct;90(4):2690-701
12815026
J Endocrinol. 2001 May;169(2):205-31
11312139
Nature. 1997 Aug 14;388(6643):686-90
9262404
J Neurosci Res. 2009 Jun;87(8):1737-47
19156871
PLoS One. 2007 Nov 21;2(11):e1196
18030331
Curr Pharm Des. 2007;13(31):3169-77
18045166
J Neurosci. 2009 Dec 2;29(48):15341-50
19955387
J Membr Biol. 1994 Oct;142(1):93-102
7707357
J Neurosci. 2010 Apr 14;30(15):5269-82
20392949
Biochem Soc Trans. 2009 Dec;37(Pt 6):1334-7
19909271
Genes Brain Behav. 2010 Jul;9(5):478-88
20180861
J Neurosci. 2009 Oct 14;29(41):12757-63
19828786
Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3662-7
14993607
J Neurosci. 2002 May 15;22(10):RC223
12006605
Neuroscience. 2007 Sep 7;148(3):794-805
17693036
Nature. 1997 Jul 3;388(6637):71-5
9214504
Growth Horm IGF Res. 2006 Aug;16(4):258-66
16914341
J Clin Invest. 1993 Oct;92(4):1824-30
8408635
Neuron. 2007 Dec 6;56(5):763-70
18054854
Neuron. 2002 Feb 14;33(4):625-33
11856535
Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8980-5
12084936
Neuroendocrinology. 2007;86(2):136-42
17643054